Previous studies have demonstrated that the RRM2 gene plays a role in regulating tumor cell proliferation in different cancers and that decreased expression of RRM2 increases sensitivity to temozolomide, gemcitabine, and platinum-based antitumor drugs11, 25, 27. This evidence concerns the gene RRM2 and neoplasm.